{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:59:15Z","timestamp":1768568355360,"version":"3.49.0"},"posted":{"date-parts":[[2024,9,9]]},"group-title":"Gastroenterology","reference-count":40,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>\n                    Even in the absence of inflammation, persistent symptoms in patients with Crohn\u2019s disease (CD) are prevalent and worsen quality of life. We previously demonstrated enrichment in sulfidogenic microbes in quiescent Crohn\u2019s disease patients with (\n                    <jats:bold>qCD+S<\/jats:bold>\n                    ) vs. without persistent GI symptoms (\n                    <jats:bold>qCD-S<\/jats:bold>\n                    ). Thus, we hypothesized that sulfur metabolic pathways would be enriched in stool while differentially abundant microbes would be associated with important sulfur-metabolic pathways in qCD+S.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    We performed a multi-center observational study nested within SPARC IBD. Quiescent inflammation was defined by fecal calprotectin level &lt;150 mcg\/g. Persistent symptoms were defined by CD-PRO2. Active CD (\n                    <jats:bold>aCD<\/jats:bold>\n                    ) and non-IBD diarrhea-predominant irritable bowel syndrome (\n                    <jats:bold>IBS-D<\/jats:bold>\n                    ) were included as controls.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Thirty-nine patients with qCD+S, 274 qCD-S, 21 aCD, and 40 IBS-D underwent paired shotgun metagenomic sequencing and untargeted metabolomic profiling. The fecal metabolome in qCD+S was significantly different relative to qCD-S and IBS-D but not aCD. Patients with qCD+S were enriched in sulfur-containing amino acid pathways, including cysteine and methionine, as well as serine, glycine, and threonine. Glutathione and nicotinate\/nicotinamide pathways were also enriched in qCD+S relative to qCD-S, suggestive of mitochondrial dysfunction, a downstream target of H\n                    <jats:sub>2<\/jats:sub>\n                    S signaling. Multi-omic integration demonstrated that enriched microbes in qCD+S were associated with important sulfur-metabolic pathways. Bacterial sulfur-metabolic genes, including\n                    <jats:italic>CTH<\/jats:italic>\n                    ,\n                    <jats:italic>isfD<\/jats:italic>\n                    ,\n                    <jats:italic>sarD<\/jats:italic>\n                    , and\n                    <jats:italic>asrC<\/jats:italic>\n                    , were dysregulated in qCD+S. Finally, sulfur metabolites with and without sulfidogenic microbes showed good accuracy in predicting presence of qCD+S.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>\n                    Microbial-derived sulfur pathways and downstream mitochondrial function are perturbed in qCD+S, which implicate H\n                    <jats:sub>2<\/jats:sub>\n                    S signaling in the pathogenesis of this condition. Future studies will determine whether targeting H\n                    <jats:sub>2<\/jats:sub>\n                    S pathways results in improved quality of life in qCD+S.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Key Messages<\/jats:title>\n                  <jats:p>\n                    <jats:bold>What is Already Known<\/jats:bold>\n                  <\/jats:p>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Even in the absence of inflammation, persistent gastrointestinal symptoms are common in Crohn\u2019s disease.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>The microbiome is altered in quiescent Crohn\u2019s disease patients with persistent symptoms, but the functional significance of these changes is unknown.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                  <jats:p>\n                    <jats:bold>What is New Here<\/jats:bold>\n                  <\/jats:p>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Sulfur metabolites and sulfur metabolic pathways were enriched in stool in quiescent Crohn\u2019s disease patients with persistent symptoms.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Multi-omic integration showed enriched microbes were associated with important sulfur metabolic pathways in quiescent Crohn\u2019s disease patients with persistent symptoms.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                  <jats:p>\n                    <jats:bold>How Can This Study Help Patient Care<\/jats:bold>\n                  <\/jats:p>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Strategies to decrease sulfidogenic microbes and associated sulfur metabolic pathways could represent a novel strategy to improve quality of life in quiescent Crohn\u2019s disease with persistent GI symptoms<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.08.24313266","type":"posted-content","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T14:20:16Z","timestamp":1725891616000},"source":"Crossref","is-referenced-by-count":0,"title":["Why Symptoms Linger in Quiescent Crohn\u2019s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways"],"prefix":"10.64898","author":[{"given":"Jonathan","family":"Golob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Chey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung","family":"Owyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.R.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-5805","authenticated-orcid":false,"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-7646","authenticated-orcid":false,"given":"Allen A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024091104150560000_2024.09.08.24313266v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.260"},{"key":"2024091104150560000_2024.09.08.24313266v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.012"},{"key":"2024091104150560000_2024.09.08.24313266v1.3","first-page":"385","article-title":"Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2024091104150560000_2024.09.08.24313266v1.4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/ibd\/izy040","article-title":"The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease","volume":"24","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2024091104150560000_2024.09.08.24313266v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304066"},{"key":"2024091104150560000_2024.09.08.24313266v1.6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjx152","article-title":"Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study]","volume":"12","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024091104150560000_2024.09.08.24313266v1.7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.gastha.2023.11.005","article-title":"The Microbiome in Quiescent Crohn\u2019s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways","volume":"3","year":"2024","journal-title":"Gastro Hep Adv"},{"key":"2024091104150560000_2024.09.08.24313266v1.8","first-page":"296","article-title":"Persistent Diarrhea in Patients With Crohn\u2019s Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2024091104150560000_2024.09.08.24313266v1.9","first-page":"2019","article-title":"Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission","volume":"18","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2024091104150560000_2024.09.08.24313266v1.10","first-page":"519","article-title":"Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2024091104150560000_2024.09.08.24313266v1.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1507645112"},{"key":"2024091104150560000_2024.09.08.24313266v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.144543"},{"key":"2024091104150560000_2024.09.08.24313266v1.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.05.056"},{"key":"2024091104150560000_2024.09.08.24313266v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.103"},{"key":"2024091104150560000_2024.09.08.24313266v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab071"},{"key":"2024091104150560000_2024.09.08.24313266v1.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.026"},{"key":"2024091104150560000_2024.09.08.24313266v1.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"2024091104150560000_2024.09.08.24313266v1.18","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2016.02.031"},{"key":"2024091104150560000_2024.09.08.24313266v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3589"},{"key":"2024091104150560000_2024.09.08.24313266v1.20","doi-asserted-by":"crossref","unstructured":"Minot SS , Barry KC , Kasman C , et al. geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response. Genome Biol 2021;22:135.","DOI":"10.1186\/s13059-021-02355-6"},{"key":"2024091104150560000_2024.09.08.24313266v1.21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1062"},{"key":"2024091104150560000_2024.09.08.24313266v1.22","doi-asserted-by":"crossref","unstructured":"Yang Y , Sun H , Zhang Y , et al. Dimensionality reduction by UMAP reinforces sample heterogeneity analysis in bulk transcriptomic data. Cell Rep 2021;36:109442.","DOI":"10.1016\/j.celrep.2021.109442"},{"key":"2024091104150560000_2024.09.08.24313266v1.23","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00691-21"},{"key":"2024091104150560000_2024.09.08.24313266v1.24","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAB382"},{"key":"2024091104150560000_2024.09.08.24313266v1.25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression Shrinkage and Selection Via the Lasso","volume":"58","year":"1996","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2024091104150560000_2024.09.08.24313266v1.26","doi-asserted-by":"publisher","DOI":"10.1214\/14-AOS1221"},{"key":"2024091104150560000_2024.09.08.24313266v1.27","doi-asserted-by":"publisher","DOI":"10.1186\/S40168-022-01296-X"},{"key":"2024091104150560000_2024.09.08.24313266v1.28","doi-asserted-by":"crossref","unstructured":"Braccia DJ , Jiang X , Pop M , et al. The Capacity to Produce Hydrogen Sulfide (H2S) via Cysteine Degradation Is Ubiquitous in the Human Gut Microbiome. Front Microbiol 2021;12:705583.","DOI":"10.3389\/fmicb.2021.705583"},{"key":"2024091104150560000_2024.09.08.24313266v1.29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MEG.0000000000000692","article-title":"Fecal calprotectin for the prediction of small-bowel Crohn\u2019s disease by capsule endoscopy: a systematic review and meta-analysis","volume":"28","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024091104150560000_2024.09.08.24313266v1.30","doi-asserted-by":"crossref","unstructured":"Paul BD , Snyder SH , Kashfi K . Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics. Redox Biol 2020;38:101772.","DOI":"10.1016\/j.redox.2020.101772"},{"key":"2024091104150560000_2024.09.08.24313266v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0135-7"},{"key":"2024091104150560000_2024.09.08.24313266v1.32","doi-asserted-by":"crossref","first-page":"2494S","DOI":"10.1093\/jn\/nxaa094","article-title":"Metabolism of Sulfur-Containing Amino Acids: How the Body Copes with Excess Methionine, Cysteine, and Sulfide","volume":"150","year":"2020","journal-title":"J Nutr"},{"key":"2024091104150560000_2024.09.08.24313266v1.33","doi-asserted-by":"crossref","first-page":"G125","DOI":"10.1152\/ajpgi.00261.2020","article-title":"Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa","volume":"320","year":"2021","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"2024091104150560000_2024.09.08.24313266v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-011-9320-3"},{"key":"2024091104150560000_2024.09.08.24313266v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.02.024"},{"key":"2024091104150560000_2024.09.08.24313266v1.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1815661116"},{"key":"2024091104150560000_2024.09.08.24313266v1.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd8377"},{"key":"2024091104150560000_2024.09.08.24313266v1.38","doi-asserted-by":"crossref","unstructured":"Liu X , Wei Y , Zhang J , et al. Isethionate is an intermediate in the degradation of sulfoacetate by the human gut pathobiont Bilophila wadsworthia . J Biol Chem 2023;299:105010.","DOI":"10.1016\/j.jbc.2023.105010"},{"key":"2024091104150560000_2024.09.08.24313266v1.39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002230"},{"key":"2024091104150560000_2024.09.08.24313266v1.40","first-page":"2074","article-title":"Steroid-Free Deep Remission at One Year Does Not Prevent Crohn\u2019s Disease Progression: Long-Term Data From the TAILORIX Trial","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.08.24313266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:11:26Z","timestamp":1768507886000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.09.08.24313266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1101\/2024.09.08.24313266","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1093\/ibd\/izae238","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,9,9]]},"subtype":"preprint"}}